These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine. Chang WH, Katz BJ, Warner JE, Vitale AT, Creel D, Digre KB. Retina; 2008; 28(10):1478-86. PubMed ID: 18997610 [Abstract] [Full Text] [Related]
3. The Demise of the Bull's Eye (Screening for Hydroxychloroquine Retinopathy). Marmor MF. Retina; 2016 Oct; 36(10):1803-5. PubMed ID: 27388736 [No Abstract] [Full Text] [Related]
4. [The ERG contribution in early diagnosis of chloroquine and hydroxychloroquine maculopathy]. Karkanová M, Matusková V, Vlková E, Dosková H, Uhmannová R. Cesk Slov Oftalmol; 2010 Apr; 66(2):62-6. PubMed ID: 20925239 [Abstract] [Full Text] [Related]
5. Clinical characteristics of hydroxychloroquine retinopathy. Payne JF, Hubbard GB, Aaberg TM, Yan J. Br J Ophthalmol; 2011 Feb; 95(2):245-50. PubMed ID: 20693556 [Abstract] [Full Text] [Related]
6. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography. Lyons JS, Severns ML. Am J Ophthalmol; 2007 May; 143(5):801-809. PubMed ID: 17336914 [Abstract] [Full Text] [Related]
8. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy. Michaelides M, Stover NB, Francis PJ, Weleber RG. Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626 [Abstract] [Full Text] [Related]
9. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy. Marmor MF, Melles RB. Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759 [Abstract] [Full Text] [Related]
10. Hydroxychloroquine retinopathy: A review of imaging. Pandya HK, Robinson M, Mandal N, Shah VA. Indian J Ophthalmol; 2015 Jul; 63(7):570-4. PubMed ID: 26458473 [Abstract] [Full Text] [Related]
11. The dilemma of hydroxychloroquine screening: new information from the multifocal ERG. Marmor MF. Am J Ophthalmol; 2005 Nov; 140(5):894-5. PubMed ID: 16310466 [No Abstract] [Full Text] [Related]
12. Hydroxychloroquine Screening Alert: Change is in the Wind. Marmor MF. Ophthalmic Surg Lasers Imaging Retina; 2017 Feb 01; 48(2):96-98. PubMed ID: 28195610 [Abstract] [Full Text] [Related]
13. Ocular toxicity of hydroxychloroquine. Yam JC, Kwok AK. Hong Kong Med J; 2006 Aug 01; 12(4):294-304. PubMed ID: 16912357 [Abstract] [Full Text] [Related]
14. Ocular safety of hydroxychloroquine. Bernstein HN. Ann Ophthalmol; 1991 Aug 01; 23(8):292-6. PubMed ID: 1952638 [Abstract] [Full Text] [Related]
15. Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer Therapy. Leung LS, Neal JW, Wakelee HA, Sequist LV, Marmor MF. Am J Ophthalmol; 2015 Oct 01; 160(4):799-805.e1. PubMed ID: 26189086 [Abstract] [Full Text] [Related]
17. Screening for hydroxychloroquine toxicity by Texas ophthalmologists. Blomquist PH, Chundru RK. J Rheumatol; 2002 Aug 01; 29(8):1665-70. PubMed ID: 12180726 [Abstract] [Full Text] [Related]
18. Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine. Kellner U, Renner AB, Tillack H. Invest Ophthalmol Vis Sci; 2006 Aug 01; 47(8):3531-8. PubMed ID: 16877425 [Abstract] [Full Text] [Related]